https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MC.jpg

Vascular Closure Devices Market Size, Share & Trends Analysis | Global | 2020-2026 | MedCore | Segmented by: Indication (Coronary and Peripheral Vascular Closure Devices) & Device Type (Invasive and Non-Invasive Devices)

  • Year: 2020
  • Scope: 10 Years
  • Region: Global
  • Published Date: 07/22/2020
  • Type: MedCore

The global vascular closure devices market size is expected to reach over $2 billion by 2027, with peripheral vascular devices accounting for the largest part of the market. Currently, the overwhelming majority of the global market share is occupied by Terumo, Cardinal Health, and Abbott Vascular.

Coronary Vascular Closure Device Market Insights

Coronary vascular closure devices (VCD) have a high penetration rate in angiographies, due to the short time allotted to the procedure. If no lesion is found during the screening, the patient can be promptly released from the hospital; a closure device facilitates the faster release of a patient. During interventional procedures, the patient stays in the hospital overnight, making time-consuming manual compression a more viable option.

Global Coronary Vascular Closure Device Market Growth, 2017-2027

The demand for coronary VCDs is correlated with the annual catheterization procedure volume, which is primarily driven by angiography and percutaneous coronary intervention (PCI) procedures. PCI procedure volume is expected to experience stable growth over the next 6 years. However, the depreciation of the device selling prices is projected, which will be driven by the increased bundling of interventional cardiology products and the commoditization of VCDs.

Peripheral Vascular Closure Device Market Insights

Growth in the peripheral vascular closure market will be driven by an increase in unit sales of both invasive and non-invasive VCDs. The sales of invasive VCDs will be driven by procedural volume increases, while the sales of non-invasive devices are expected to increase more quickly as smaller devices are increasingly used and radial approaches become more common.

Global Peripheral Vascular Closure Devices Market Size Growth, 2016-2026

Additionally, as more devices are catering towards large-bore holes, the small-bore procedures are further being cannibalized. High growth in total procedure volumes and increasing penetration of vascular closure devices will preserve moderate growth in the small-bore market. As competitive pressures remain present, the selling prices of vascular closure devices are expected to continue on the downward trend.

What Are The Top Vascular Closure Companies?

Globally, over 60% of the global vascular closure device (VCD) market was controlled by three key companies – Terumo, Cardinal Health, and Abbott Vascular.

Top Global Vascular Closure Companies

Terumo, Abbott Vascular, and Cardinal Health held the strongest positions within the largest global regions, including North America and Europe. For example, Terumo held the leading position in the global coronary VCD market, due to its stronghold of both invasive and non-invasive VCD market segments. The company entered the invasive VCD market in January 2017, through the acquisition of St. Jude Medical’s coronary and peripheral vascular closure product lines.
Terumo currently offers the Angio-Seal™ and FemoSeal™ product lines, which both feature three bioabsorbable components.

Abbott Vascular, on the other hand, is the leading competitor in the global peripheral VCD market. Abbott generates the majority of its VCD revenue in the large-bore invasive VCD segment, where it held a near-monopoly. However, the company’s of the global invasive VCD market is expected to erode over the forecast period as emerging competitors launch novel devices capable of closing a large-bore puncture with a single device.

Cardinal Health holds the second-leading position in the global coronary VCD market due solely to its presence in the invasive VCD market. The company entered the global market through its acquisition of AccessClosure in 2014, effectively adding VCDs to its portfolio. Cardinal Health is also the third-leading position in the peripheral VCD market, trailing behind Abbot and Terumo. The company expanded its stake in the global market in 2015, with the acquisition of Cordis, and now offers Mynx™ and EXOSEAL™ product lines.

Top Global Vascular Closure Companies Analyzed

  • Abbott
  • Advanced Vascular Dynamics
  • Cardinal Health
  • Cardiva Medical
  • InSeal Medical
  • Marine Polymer Technologies
  • Medeon Biodesign
  • Merit Medical
  • Pfizer
  • Rex Medical
  • Teleflex
  • Terumo
  • Transluminal Technologies
  • Tricol Biomedical
  • TZ Medical
  • Vivasure Medical

Market Segmentation Summary

While this global report suite contains all global vascular closure device market data, each of the market segments is also available as a stand-alone report, MedCore. This allows you to get access to only the vascular closure device market research that you need.

  • Coronary Vascular Closure Device Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
    • Device Type: Invasive and Non-invasive Vascular Closure Devices.
  • Peripheral Vascular Closure Device Market | Global | 2020-2026 | MedCore – The chapter contains the market analysis which is categorized by:
    • Device Type: Invasive and Non-invasive Vascular Closure Devices;
    • Application Type:* Femoral and Radial Vascular Closure Devices.

*Research coverage might vary by global region. Request your complimentary research summary to learn more.

Global Research Scope Summary

Report Attribute Details
Regions North America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2020 – Coronary VCD Market
2019 – Peripheral VCD Market
Forecast 2021-2027 – Coronary VCD Market
2020-2026 – Peripheral VCD Market
Historical Data 2017-2020 – Coronary VCD Market
2016-2019 – Peripheral VCD Market
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
 

FREE Sample Report

For a Full Table of Contents, please contact us at [email protected] or send a request for a Report Sample.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology